Gene Symbol | Gene ID | Gene Info |
---|---|---|
Tlx2
|
ENSMUSG00000068327.3 | T cell leukemia, homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_83066104_83066474 | Tlx2 | 3936 | 0.062382 | -0.49 | 5.8e-05 | Click! |
chr6_83064507_83064995 | Tlx2 | 5474 | 0.055833 | -0.29 | 2.2e-02 | Click! |
chr6_83066623_83066774 | Tlx2 | 3527 | 0.065594 | -0.28 | 3.0e-02 | Click! |
chr6_83072003_83072625 | Tlx2 | 2021 | 0.095004 | -0.25 | 5.7e-02 | Click! |
chr6_83072705_83072995 | Tlx2 | 2557 | 0.077258 | -0.20 | 1.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_131638462_131638811 | 12.42 |
Ctse |
cathepsin E |
142 |
0.95 |
chr3_116563017_116563467 | 10.66 |
Lrrc39 |
leucine rich repeat containing 39 |
264 |
0.81 |
chr6_41703661_41704308 | 9.77 |
Kel |
Kell blood group |
355 |
0.81 |
chr7_103812275_103812465 | 9.38 |
Hbb-bt |
hemoglobin, beta adult t chain |
1626 |
0.15 |
chr5_64810297_64813272 | 9.23 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr13_4233789_4234486 | 9.03 |
Akr1c19 |
aldo-keto reductase family 1, member C19 |
397 |
0.81 |
chr17_71204583_71205351 | 8.87 |
Lpin2 |
lipin 2 |
291 |
0.89 |
chr7_48879180_48879915 | 8.85 |
E2f8 |
E2F transcription factor 8 |
1457 |
0.26 |
chr7_143005720_143007083 | 8.20 |
Tspan32 |
tetraspanin 32 |
473 |
0.68 |
chr14_40992016_40992401 | 7.18 |
Prxl2a |
peroxiredoxin like 2A |
10896 |
0.17 |
chr18_62176067_62177775 | 7.13 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr11_58918085_58918881 | 6.97 |
Btnl10 |
butyrophilin-like 10 |
426 |
0.61 |
chr9_48338929_48340200 | 6.94 |
Nxpe2 |
neurexophilin and PC-esterase domain family, member 2 |
1270 |
0.48 |
chr12_13180713_13181236 | 6.81 |
Gm24208 |
predicted gene, 24208 |
17211 |
0.16 |
chr7_133702217_133702505 | 6.63 |
Uros |
uroporphyrinogen III synthase |
177 |
0.91 |
chr4_133872481_133873035 | 6.57 |
Gm12977 |
predicted gene 12977 |
276 |
0.47 |
chr3_102165384_102165916 | 6.49 |
Vangl1 |
VANGL planar cell polarity 1 |
290 |
0.87 |
chr4_62516521_62517025 | 6.40 |
Alad |
aminolevulinate, delta-, dehydratase |
3108 |
0.15 |
chr7_99594627_99596228 | 6.36 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr19_53194082_53195694 | 6.35 |
Add3 |
adducin 3 (gamma) |
65 |
0.97 |
chr8_84701273_84703379 | 6.29 |
Lyl1 |
lymphoblastomic leukemia 1 |
545 |
0.59 |
chr3_102164896_102165102 | 6.26 |
Vangl1 |
VANGL planar cell polarity 1 |
941 |
0.48 |
chr19_10015065_10016667 | 6.19 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr9_98298003_98298191 | 6.01 |
Nmnat3 |
nicotinamide nucleotide adenylyltransferase 3 |
1435 |
0.43 |
chr18_54422355_54422833 | 5.95 |
Redrum |
Redrum, erythroid developmental long intergenic non-protein coding transcript |
299 |
0.93 |
chr5_67815409_67815775 | 5.90 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
261 |
0.89 |
chr10_75939108_75939976 | 5.82 |
Gm867 |
predicted gene 867 |
1069 |
0.25 |
chr18_11058575_11059292 | 5.77 |
Gata6 |
GATA binding protein 6 |
114 |
0.97 |
chr6_72389419_72390767 | 5.76 |
Vamp8 |
vesicle-associated membrane protein 8 |
182 |
0.89 |
chr2_121235231_121235799 | 5.74 |
Trp53bp1 |
transformation related protein 53 binding protein 1 |
174 |
0.93 |
chr16_95456632_95459094 | 5.65 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr7_45920062_45921322 | 5.63 |
Emp3 |
epithelial membrane protein 3 |
159 |
0.87 |
chr11_102360845_102363484 | 5.60 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr7_24371543_24371978 | 5.59 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
1422 |
0.22 |
chr3_132629876_132630281 | 5.53 |
Gimd1 |
GIMAP family P-loop NTPase domain containing 1 |
63 |
0.97 |
chr14_66279066_66281333 | 5.47 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr1_173332160_173333204 | 5.38 |
Ackr1 |
atypical chemokine receptor 1 (Duffy blood group) |
820 |
0.54 |
chr6_55336550_55338274 | 5.34 |
Aqp1 |
aquaporin 1 |
980 |
0.5 |
chr8_80867565_80868184 | 5.34 |
Gm31105 |
predicted gene, 31105 |
12066 |
0.18 |
chr10_19593516_19594017 | 5.31 |
Ifngr1 |
interferon gamma receptor 1 |
1693 |
0.36 |
chr14_31166307_31168596 | 5.30 |
Stab1 |
stabilin 1 |
1144 |
0.34 |
chr11_61958530_61958961 | 5.28 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
1930 |
0.24 |
chr5_107872448_107872893 | 5.18 |
Evi5 |
ecotropic viral integration site 5 |
2374 |
0.16 |
chr11_95340365_95340536 | 5.16 |
Fam117a |
family with sequence similarity 117, member A |
488 |
0.69 |
chr17_34998518_34998899 | 5.03 |
Vars |
valyl-tRNA synthetase |
2279 |
0.08 |
chr19_7019038_7019379 | 4.92 |
Fermt3 |
fermitin family member 3 |
137 |
0.9 |
chr4_117473269_117473989 | 4.87 |
Rnf220 |
ring finger protein 220 |
21382 |
0.13 |
chr11_87107735_87108681 | 4.84 |
Prr11 |
proline rich 11 |
500 |
0.55 |
chr7_24370279_24371432 | 4.76 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
517 |
0.59 |
chr2_163506859_163507228 | 4.75 |
Hnf4a |
hepatic nuclear factor 4, alpha |
235 |
0.88 |
chr8_128487802_128488509 | 4.74 |
Nrp1 |
neuropilin 1 |
128758 |
0.05 |
chr1_130421898_130423113 | 4.74 |
Cd55b |
CD55 molecule, decay accelerating factor for complement B |
235 |
0.58 |
chrX_11664777_11665621 | 4.73 |
Gm14513 |
predicted gene 14513 |
18925 |
0.24 |
chr11_117779316_117780928 | 4.71 |
Tmc6 |
transmembrane channel-like gene family 6 |
472 |
0.61 |
chr4_154926952_154928851 | 4.71 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr11_5897192_5898699 | 4.64 |
Myl7 |
myosin, light polypeptide 7, regulatory |
837 |
0.46 |
chr5_67814073_67814466 | 4.63 |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
961 |
0.48 |
chr16_91804661_91805209 | 4.59 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
299 |
0.9 |
chr8_104535643_104535836 | 4.57 |
Car7 |
carbonic anhydrase 7 |
1039 |
0.28 |
chr15_78325871_78326729 | 4.57 |
Csf2rb |
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
244 |
0.88 |
chr7_127767459_127768302 | 4.53 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
1935 |
0.14 |
chr10_39612918_39613668 | 4.47 |
Traf3ip2 |
TRAF3 interacting protein 2 |
359 |
0.48 |
chr19_6968781_6970375 | 4.47 |
Plcb3 |
phospholipase C, beta 3 |
130 |
0.89 |
chr5_139734507_139735058 | 4.44 |
Micall2 |
MICAL-like 2 |
1554 |
0.31 |
chr18_44554845_44555098 | 4.44 |
Mcc |
mutated in colorectal cancers |
35455 |
0.2 |
chr11_78074087_78074838 | 4.43 |
Mir451b |
microRNA 451b |
1221 |
0.18 |
chr8_61902204_61902661 | 4.38 |
Palld |
palladin, cytoskeletal associated protein |
237 |
0.92 |
chr3_96559570_96560186 | 4.37 |
Txnip |
thioredoxin interacting protein |
155 |
0.87 |
chr8_41015082_41015919 | 4.36 |
Mtus1 |
mitochondrial tumor suppressor 1 |
820 |
0.53 |
chr13_23497689_23499269 | 4.35 |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
9622 |
0.06 |
chr4_53143397_53144061 | 4.34 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
16166 |
0.21 |
chr13_20150477_20151150 | 4.29 |
Elmo1 |
engulfment and cell motility 1 |
34394 |
0.22 |
chr11_62005417_62006894 | 4.28 |
Specc1 |
sperm antigen with calponin homology and coiled-coil domains 1 |
805 |
0.61 |
chr12_111442182_111444685 | 4.27 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr9_106156833_106157412 | 4.25 |
Glyctk |
glycerate kinase |
128 |
0.86 |
chr5_134914619_134915072 | 4.24 |
Cldn13 |
claudin 13 |
681 |
0.46 |
chr6_31612888_31614126 | 4.22 |
Gm43154 |
predicted gene 43154 |
8218 |
0.19 |
chr4_106804374_106805428 | 4.21 |
Acot11 |
acyl-CoA thioesterase 11 |
97 |
0.96 |
chr17_40812075_40812470 | 4.18 |
Rhag |
Rhesus blood group-associated A glycoprotein |
1088 |
0.44 |
chr11_87756102_87757558 | 4.17 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr5_64149523_64150517 | 4.17 |
Gm22559 |
predicted gene, 22559 |
5772 |
0.14 |
chr7_75612178_75613652 | 4.15 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr1_171281964_171282352 | 4.15 |
Usp21 |
ubiquitin specific peptidase 21 |
748 |
0.31 |
chr10_115817324_115818606 | 4.14 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr15_76666348_76670076 | 4.12 |
Foxh1 |
forkhead box H1 |
1590 |
0.15 |
chr3_89136417_89137539 | 4.11 |
Pklr |
pyruvate kinase liver and red blood cell |
355 |
0.69 |
chr15_9080950_9081426 | 4.10 |
Nadk2 |
NAD kinase 2, mitochondrial |
4612 |
0.25 |
chr15_38542701_38543715 | 4.07 |
Azin1 |
antizyme inhibitor 1 |
23942 |
0.1 |
chr6_99095299_99096526 | 4.06 |
Foxp1 |
forkhead box P1 |
293 |
0.93 |
chr9_21029266_21030734 | 4.05 |
Icam4 |
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
546 |
0.46 |
chr5_36712472_36713424 | 4.00 |
D5Ertd579e |
DNA segment, Chr 5, ERATO Doi 579, expressed |
16924 |
0.12 |
chr4_150519034_150519503 | 3.97 |
Rere |
arginine glutamic acid dipeptide (RE) repeats |
30875 |
0.18 |
chr3_144198213_144200687 | 3.96 |
Gm43445 |
predicted gene 43445 |
188 |
0.94 |
chr1_153751697_153752752 | 3.93 |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
256 |
0.82 |
chr7_97453001_97454277 | 3.91 |
Kctd14 |
potassium channel tetramerisation domain containing 14 |
417 |
0.79 |
chr10_59403301_59404650 | 3.91 |
Pla2g12b |
phospholipase A2, group XIIB |
315 |
0.88 |
chr12_33316100_33316532 | 3.89 |
Atxn7l1 |
ataxin 7-like 1 |
911 |
0.62 |
chr2_28620746_28622145 | 3.88 |
Gfi1b |
growth factor independent 1B |
500 |
0.68 |
chr8_94984127_94985009 | 3.87 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
98 |
0.95 |
chr11_115901935_115902451 | 3.85 |
Smim5 |
small integral membrane protein 5 |
1991 |
0.16 |
chr18_20666097_20666725 | 3.84 |
Ttr |
transthyretin |
1131 |
0.34 |
chr1_176836732_176837286 | 3.81 |
Gm38158 |
predicted gene, 38158 |
1285 |
0.31 |
chr9_36766056_36766207 | 3.81 |
Stt3a |
STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae) |
1219 |
0.31 |
chr15_78571384_78571718 | 3.80 |
Rac2 |
Rac family small GTPase 2 |
1230 |
0.3 |
chr7_142576289_142578620 | 3.77 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr15_78304979_78305669 | 3.76 |
Csf2rb2 |
colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) |
296 |
0.85 |
chr4_86885709_86886839 | 3.76 |
Acer2 |
alkaline ceramidase 2 |
11860 |
0.21 |
chr11_75449209_75449924 | 3.76 |
Wdr81 |
WD repeat domain 81 |
214 |
0.84 |
chr17_47909108_47910390 | 3.75 |
Gm15556 |
predicted gene 15556 |
12629 |
0.13 |
chr11_98581976_98582749 | 3.73 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5006 |
0.11 |
chr16_20701494_20702997 | 3.72 |
Fam131a |
family with sequence similarity 131, member A |
6070 |
0.08 |
chr11_119392018_119392570 | 3.70 |
Rnf213 |
ring finger protein 213 |
806 |
0.49 |
chr18_10532033_10532184 | 3.69 |
Gm24894 |
predicted gene, 24894 |
19298 |
0.15 |
chrX_85613609_85614890 | 3.68 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr6_114659895_114660064 | 3.68 |
Atg7 |
autophagy related 7 |
1915 |
0.41 |
chr9_120114964_120115764 | 3.68 |
Slc25a38 |
solute carrier family 25, member 38 |
375 |
0.69 |
chr1_136960004_136960405 | 3.68 |
Nr5a2 |
nuclear receptor subfamily 5, group A, member 2 |
176 |
0.96 |
chr3_96404203_96405307 | 3.68 |
Gm26654 |
predicted gene, 26654 |
2374 |
0.09 |
chr4_104876046_104876409 | 3.67 |
C8a |
complement component 8, alpha polypeptide |
156 |
0.96 |
chr2_58158217_58158858 | 3.67 |
Cytip |
cytohesin 1 interacting protein |
1582 |
0.38 |
chr10_43593483_43593753 | 3.65 |
F930017D23Rik |
RIKEN cDNA F930017D23 gene |
179 |
0.93 |
chr3_20153107_20153379 | 3.64 |
Gyg |
glycogenin |
1826 |
0.36 |
chr2_105125289_105128976 | 3.63 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr14_41007005_41008239 | 3.62 |
Prxl2a |
peroxiredoxin like 2A |
644 |
0.68 |
chr10_60346425_60348008 | 3.62 |
Vsir |
V-set immunoregulatory receptor |
204 |
0.94 |
chr11_78984345_78985263 | 3.61 |
Lgals9 |
lectin, galactose binding, soluble 9 |
27 |
0.98 |
chr15_83496013_83496555 | 3.61 |
Ttll1 |
tubulin tyrosine ligase-like 1 |
14509 |
0.12 |
chr4_154024404_154026596 | 3.61 |
Smim1 |
small integral membrane protein 1 |
116 |
0.93 |
chrX_8271051_8272966 | 3.61 |
Slc38a5 |
solute carrier family 38, member 5 |
366 |
0.82 |
chr11_104578496_104579513 | 3.59 |
Myl4 |
myosin, light polypeptide 4 |
1321 |
0.29 |
chr19_17323079_17323350 | 3.58 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
12222 |
0.21 |
chr11_95841518_95842457 | 3.58 |
Abi3 |
ABI gene family, member 3 |
111 |
0.73 |
chr7_28582069_28582250 | 3.57 |
Pak4 |
p21 (RAC1) activated kinase 4 |
13922 |
0.08 |
chr10_34483356_34484742 | 3.57 |
Frk |
fyn-related kinase |
517 |
0.83 |
chr8_57319308_57320679 | 3.57 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr7_45238275_45239242 | 3.56 |
Cd37 |
CD37 antigen |
38 |
0.92 |
chr12_76709116_76709328 | 3.55 |
Sptb |
spectrin beta, erythrocytic |
801 |
0.65 |
chr1_75445319_75447338 | 3.55 |
Gmppa |
GDP-mannose pyrophosphorylase A |
4104 |
0.1 |
chr4_141536335_141538488 | 3.53 |
Spen |
spen family transcription repressor |
842 |
0.51 |
chr12_78904719_78905643 | 3.53 |
Plek2 |
pleckstrin 2 |
1783 |
0.34 |
chr7_135713600_135714219 | 3.52 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
2452 |
0.24 |
chr8_60952376_60953209 | 3.52 |
Clcn3 |
chloride channel, voltage-sensitive 3 |
1956 |
0.29 |
chr10_40140777_40141166 | 3.51 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1283 |
0.36 |
chr2_26011313_26011475 | 3.51 |
Ubac1 |
ubiquitin associated domain containing 1 |
441 |
0.76 |
chr8_84902494_84903152 | 3.50 |
Klf1 |
Kruppel-like factor 1 (erythroid) |
895 |
0.3 |
chr19_46304366_46306224 | 3.50 |
4833438C02Rik |
RIKEN cDNA 4833438C02 gene |
310 |
0.52 |
chrX_9274237_9274969 | 3.47 |
Xk |
X-linked Kx blood group |
1847 |
0.24 |
chr3_129836696_129837785 | 3.47 |
Cfi |
complement component factor i |
503 |
0.7 |
chr8_94172106_94173724 | 3.47 |
Mt2 |
metallothionein 2 |
55 |
0.87 |
chr3_60031760_60032307 | 3.45 |
Aadac |
arylacetamide deacetylase |
157 |
0.95 |
chr4_123564242_123564871 | 3.44 |
Macf1 |
microtubule-actin crosslinking factor 1 |
138 |
0.96 |
chr2_180331778_180331982 | 3.42 |
Gata5os |
GATA binding protein 5, opposite strand |
977 |
0.42 |
chr3_94784215_94785215 | 3.40 |
Cgn |
cingulin |
1736 |
0.25 |
chr4_119116525_119117102 | 3.39 |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
7899 |
0.1 |
chr15_102460089_102460942 | 3.38 |
Prr13 |
proline rich 13 |
432 |
0.68 |
chr2_80036063_80037075 | 3.35 |
Pde1a |
phosphodiesterase 1A, calmodulin-dependent |
2460 |
0.41 |
chr10_117149983_117150315 | 3.35 |
Frs2 |
fibroblast growth factor receptor substrate 2 |
1615 |
0.3 |
chr17_29490879_29492158 | 3.33 |
Gm26885 |
predicted gene, 26885 |
47 |
0.71 |
chr2_172393314_172394463 | 3.33 |
Cass4 |
Cas scaffolding protein family member 4 |
12 |
0.97 |
chr4_63152318_63152930 | 3.32 |
Ambp |
alpha 1 microglobulin/bikunin precursor |
1549 |
0.36 |
chr6_72391190_72391463 | 3.31 |
Vamp8 |
vesicle-associated membrane protein 8 |
623 |
0.55 |
chr19_47403397_47403666 | 3.30 |
Sh3pxd2a |
SH3 and PX domains 2A |
6828 |
0.23 |
chr16_72765255_72765651 | 3.29 |
Robo1 |
roundabout guidance receptor 1 |
102249 |
0.09 |
chr18_5603232_5604403 | 3.28 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
73 |
0.96 |
chr12_33315477_33315814 | 3.28 |
Atxn7l1 |
ataxin 7-like 1 |
240 |
0.94 |
chr9_22135450_22135674 | 3.28 |
Acp5 |
acid phosphatase 5, tartrate resistant |
129 |
0.9 |
chr11_78983972_78984266 | 3.27 |
Lgals9 |
lectin, galactose binding, soluble 9 |
712 |
0.67 |
chr16_92695033_92696333 | 3.27 |
Runx1 |
runt related transcription factor 1 |
188 |
0.96 |
chr1_134418556_134420350 | 3.27 |
Adipor1 |
adiponectin receptor 1 |
3889 |
0.13 |
chr6_49208234_49209239 | 3.27 |
Igf2bp3 |
insulin-like growth factor 2 mRNA binding protein 3 |
5425 |
0.17 |
chr3_14886252_14887458 | 3.26 |
Car2 |
carbonic anhydrase 2 |
216 |
0.94 |
chr11_87748405_87749482 | 3.26 |
Mir142hg |
Mir142 host gene (non-protein coding) |
6634 |
0.09 |
chr15_59263361_59263897 | 3.24 |
Gm36617 |
predicted gene, 36617 |
11767 |
0.16 |
chr7_38104097_38104460 | 3.24 |
Ccne1 |
cyclin E1 |
2630 |
0.24 |
chr7_100854551_100855928 | 3.24 |
Relt |
RELT tumor necrosis factor receptor |
190 |
0.92 |
chr14_33184420_33185123 | 3.24 |
Wdfy4 |
WD repeat and FYVE domain containing 4 |
295 |
0.87 |
chr4_155468952_155469786 | 3.23 |
Tmem52 |
transmembrane protein 52 |
222 |
0.87 |
chr8_13204650_13205222 | 3.23 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
4116 |
0.12 |
chr11_117798237_117798922 | 3.23 |
6030468B19Rik |
RIKEN cDNA 6030468B19 gene |
919 |
0.33 |
chr1_125676834_125678312 | 3.22 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr6_117888079_117889227 | 3.20 |
Gm29509 |
predicted gene 29509 |
10548 |
0.11 |
chr9_21961394_21962913 | 3.19 |
Epor |
erythropoietin receptor |
411 |
0.68 |
chr1_120258372_120258984 | 3.19 |
Steap3 |
STEAP family member 3 |
6577 |
0.26 |
chr18_56870048_56870991 | 3.18 |
Gm18087 |
predicted gene, 18087 |
45569 |
0.14 |
chr7_120978738_120978889 | 3.18 |
Cdr2 |
cerebellar degeneration-related 2 |
2977 |
0.14 |
chr6_41701642_41702158 | 3.17 |
Kel |
Kell blood group |
2439 |
0.19 |
chr11_48801825_48801976 | 3.17 |
Snord96a |
small nucleolar RNA, C/D box 96A |
132 |
0.85 |
chr4_104766381_104766876 | 3.17 |
C8b |
complement component 8, beta polypeptide |
233 |
0.96 |
chr2_173033564_173034786 | 3.17 |
Gm14453 |
predicted gene 14453 |
405 |
0.79 |
chr8_105294915_105296293 | 3.15 |
Exoc3l |
exocyst complex component 3-like |
336 |
0.65 |
chrX_38575712_38576177 | 3.15 |
Cul4b |
cullin 4B |
239 |
0.93 |
chr2_102900531_102901984 | 3.11 |
Cd44 |
CD44 antigen |
89 |
0.97 |
chr3_96237337_96238950 | 3.11 |
H3c15 |
H3 clustered histone 15 |
984 |
0.15 |
chr2_113847625_113848666 | 3.11 |
Arhgap11a |
Rho GTPase activating protein 11A |
152 |
0.96 |
chr2_91635021_91635643 | 3.08 |
F2 |
coagulation factor II |
1063 |
0.36 |
chr17_71019478_71020561 | 3.08 |
Myom1 |
myomesin 1 |
428 |
0.76 |
chr7_132771931_132772484 | 3.08 |
Fam53b |
family with sequence similarity 53, member B |
4709 |
0.23 |
chr7_4629257_4630354 | 3.06 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr8_117701899_117703135 | 3.06 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
430 |
0.77 |
chr11_95778990_95779141 | 3.05 |
Polr2k-ps |
polymerase (RNA) II (DNA directed) polypeptide K, pseudogene |
17574 |
0.11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 12.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.6 | 7.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
2.4 | 12.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.3 | 9.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
2.3 | 6.9 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.3 | 6.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.2 | 6.7 | GO:0036394 | amylase secretion(GO:0036394) |
2.2 | 6.5 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
2.1 | 6.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.9 | 7.8 | GO:0008228 | opsonization(GO:0008228) |
1.9 | 3.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.9 | 7.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.7 | 6.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.7 | 3.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.7 | 5.0 | GO:0042938 | dipeptide transport(GO:0042938) |
1.6 | 6.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.6 | 17.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.6 | 4.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.5 | 4.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.5 | 4.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.5 | 4.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.4 | 4.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.4 | 4.3 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.4 | 32.7 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
1.3 | 1.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.3 | 4.0 | GO:0050904 | diapedesis(GO:0050904) |
1.3 | 5.2 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.2 | 3.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.2 | 8.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.2 | 7.2 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
1.2 | 2.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
1.2 | 2.4 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.2 | 3.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
1.2 | 1.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.1 | 4.6 | GO:0003175 | tricuspid valve development(GO:0003175) |
1.1 | 2.3 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.1 | 4.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.1 | 3.3 | GO:0002432 | granuloma formation(GO:0002432) |
1.1 | 3.3 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.1 | 1.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
1.1 | 2.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 4.3 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.0 | 2.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.0 | 1.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.0 | 3.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.0 | 4.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.0 | 3.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
1.0 | 3.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.0 | 11.0 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.0 | 3.0 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 3.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.0 | 1.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.0 | 8.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 1.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.0 | 2.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.0 | 2.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.9 | 5.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.9 | 2.8 | GO:0070295 | renal water absorption(GO:0070295) |
0.9 | 2.8 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.9 | 2.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.9 | 7.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.9 | 3.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.9 | 2.7 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.9 | 2.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.9 | 3.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.9 | 3.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.9 | 3.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.9 | 2.7 | GO:1903969 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
0.9 | 2.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.9 | 3.5 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.9 | 7.1 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.9 | 1.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.9 | 4.4 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.9 | 3.5 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
0.9 | 5.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.9 | 6.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.9 | 4.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.9 | 2.6 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.9 | 2.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
0.9 | 2.6 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.9 | 6.0 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.8 | 1.7 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.8 | 3.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.8 | 1.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.8 | 2.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.8 | 4.8 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 4.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 0.8 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.8 | 2.4 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.8 | 3.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 2.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.8 | 2.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.8 | 7.6 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.8 | 2.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.8 | 0.8 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 6.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 1.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.7 | 0.7 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.7 | 2.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.7 | 5.9 | GO:0097286 | iron ion import(GO:0097286) |
0.7 | 2.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.7 | 3.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.7 | 1.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 2.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.7 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.7 | 2.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 2.8 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.7 | 3.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.7 | 0.7 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
0.7 | 6.3 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.7 | 1.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.7 | 4.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.7 | 2.8 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.7 | 2.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.7 | 2.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.7 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 4.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 2.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.7 | 0.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.7 | 4.0 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.7 | 4.0 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
0.7 | 2.0 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.7 | 2.0 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.7 | 2.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.7 | 2.0 | GO:0001796 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
0.7 | 1.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 1.3 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.7 | 2.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 3.9 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.7 | 6.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 3.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.7 | 1.3 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.6 | 1.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.6 | 1.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.6 | 11.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.6 | 1.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.6 | 1.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.6 | 0.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.6 | 1.3 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.6 | 1.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.6 | 0.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.6 | 5.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.6 | 1.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.6 | 1.3 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.6 | 2.5 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.6 | 0.6 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 3.1 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.6 | 1.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.6 | 1.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.6 | 7.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.6 | 1.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.6 | 0.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.6 | 4.9 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.6 | 0.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.6 | 2.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.6 | 1.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 1.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 5.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.6 | 1.8 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.6 | 4.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.6 | 1.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.6 | 2.3 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.6 | 1.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 1.7 | GO:0072537 | fibroblast activation(GO:0072537) |
0.6 | 1.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.6 | 1.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.6 | 2.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.6 | 2.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.6 | 2.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 4.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.6 | 0.6 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.6 | 5.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.6 | 0.6 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 0.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.6 | 0.6 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.6 | 1.7 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.6 | 2.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.6 | 0.6 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.6 | 2.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.5 | 1.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 2.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.5 | 1.1 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.5 | 2.2 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.5 | 6.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 0.5 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.5 | 1.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.5 | 1.6 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 3.2 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.5 | 1.6 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.5 | 2.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 1.6 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.5 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 1.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.5 | 2.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.5 | 0.5 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
0.5 | 3.7 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 1.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.5 | 1.6 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.5 | 3.7 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
0.5 | 1.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.5 | 0.5 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.5 | 2.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.5 | 2.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.5 | 1.5 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 1.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 2.6 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.5 | 1.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.5 | 0.5 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.5 | 1.5 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.5 | 1.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 0.5 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.5 | 2.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 1.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 1.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.5 | 2.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.5 | 1.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.5 | 0.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.5 | 1.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 10.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.5 | 2.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 3.0 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.5 | 1.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.5 | 2.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.5 | 1.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.5 | 2.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.5 | 3.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.5 | 1.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.5 | 2.9 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.5 | 2.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 1.5 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 1.5 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.5 | 2.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.5 | 3.4 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.5 | 1.5 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.5 | 2.4 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.5 | 1.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.5 | 1.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.5 | 2.9 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.4 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 2.9 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.5 | 2.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.5 | 1.9 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.5 | 0.5 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.5 | 1.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.5 | 1.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.5 | 1.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.5 | 9.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.5 | 1.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 2.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.5 | 1.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.5 | 1.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.5 | 2.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.5 | 1.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 1.8 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.5 | 1.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 0.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 1.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.5 | 0.5 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.5 | 3.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.5 | 0.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.5 | 2.3 | GO:0046618 | drug export(GO:0046618) |
0.5 | 0.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.5 | 3.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 1.3 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.4 | 3.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 1.3 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.4 | 3.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 2.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.4 | 3.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 0.9 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.4 | 1.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.4 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.4 | 4.3 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.4 | 0.9 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 10.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 0.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.4 | 0.9 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.4 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.4 | 4.7 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.4 | 8.0 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.4 | 3.4 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.4 | 0.4 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.4 | 0.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.4 | 2.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 2.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.4 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 0.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 2.1 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.4 | 0.4 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.4 | 1.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.4 | 2.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.4 | 0.4 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.4 | 1.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.4 | 0.8 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
0.4 | 0.4 | GO:1903901 | negative regulation of viral life cycle(GO:1903901) |
0.4 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 0.4 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 0.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.4 | 1.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.4 | 2.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.4 | 0.8 | GO:0061010 | gall bladder development(GO:0061010) |
0.4 | 2.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
0.4 | 1.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 0.8 | GO:0072718 | response to cisplatin(GO:0072718) |
0.4 | 0.8 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.4 | 8.7 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.4 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 0.4 | GO:0035482 | gastric motility(GO:0035482) |
0.4 | 1.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.4 | 0.8 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.4 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 1.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.4 | 0.4 | GO:0001803 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.4 | 2.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.4 | 0.8 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.4 | 3.4 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.4 | 4.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 1.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.4 | 2.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.4 | 3.8 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.4 | 4.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.4 | 1.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.4 | 6.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.4 | 0.7 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.4 | 1.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 3.7 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.4 | 1.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 4.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.4 | 0.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.4 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.4 | 1.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 0.4 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.4 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.4 | 1.1 | GO:0009597 | detection of virus(GO:0009597) |
0.4 | 1.1 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 0.7 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.4 | 2.1 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.4 | 2.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.4 | 1.8 | GO:0018904 | ether metabolic process(GO:0018904) |
0.4 | 3.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 1.4 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.4 | 7.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 1.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 5.3 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 1.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.4 | 0.4 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 1.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 1.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 2.1 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.3 | 1.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.3 | 1.4 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.3 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 1.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 1.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 1.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.3 | 1.4 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 1.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 | 1.0 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.3 | 1.4 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.3 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 1.7 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 1.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.3 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.3 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.3 | 3.0 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.3 | 1.7 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.3 | 2.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.3 | 1.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.7 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.3 | 5.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 2.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.3 | 8.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 0.3 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 0.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.3 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 3.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 1.3 | GO:0039529 | RIG-I signaling pathway(GO:0039529) regulation of RIG-I signaling pathway(GO:0039535) |
0.3 | 0.6 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.3 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 1.3 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.6 | GO:0019081 | viral translation(GO:0019081) |
0.3 | 0.6 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 2.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.3 | 1.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 1.3 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 2.5 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.3 | 1.3 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 2.5 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.3 | 4.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.3 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 0.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 1.3 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.3 | 3.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.9 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.3 | 0.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.9 | GO:0018214 | protein carboxylation(GO:0018214) |
0.3 | 1.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.3 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.3 | 1.2 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.3 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.6 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.3 | 1.2 | GO:0033131 | regulation of glucokinase activity(GO:0033131) |
0.3 | 0.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 0.6 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.3 | 1.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 2.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 1.8 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 1.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.3 | 0.6 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 0.9 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.3 | 0.9 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.3 | 0.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 2.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.3 | 1.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.3 | 0.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.3 | 3.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.3 | 0.3 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 1.5 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 5.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 0.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 3.6 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.3 | 1.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.3 | 0.3 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.3 | 3.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 1.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.3 | 0.3 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.3 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 0.6 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.3 | 6.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.3 | 2.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 2.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.9 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 0.9 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.3 | 0.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.9 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.5 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.3 | 0.6 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.3 | 1.2 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
0.3 | 3.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 0.3 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 1.2 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.3 | 0.9 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 0.9 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.3 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.3 | 0.3 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.3 | 6.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.3 | 4.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 1.7 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.3 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 5.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 1.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.3 | 2.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 0.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.3 | 0.3 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
0.3 | 2.0 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 0.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.3 | 0.6 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.3 | 2.2 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.3 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.8 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.3 | 0.8 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.3 | 1.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.8 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.3 | 0.8 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.3 | 0.6 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.3 | 1.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 1.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 2.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.3 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.3 | 1.7 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.3 | 2.2 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.3 | 0.5 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.3 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.3 | GO:0046137 | negative regulation of vitamin metabolic process(GO:0046137) regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 0.3 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.3 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.3 | 1.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.4 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.3 | 0.5 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.8 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.3 | 0.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.3 | 1.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 1.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.3 | 1.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.3 | 0.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.1 | GO:0019240 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
0.3 | 0.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 0.8 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 0.8 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.3 | 1.6 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.3 | 1.3 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 0.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.3 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.5 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.3 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.3 | 0.8 | GO:0009180 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 0.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.3 | 1.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.3 | 0.8 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.3 | 1.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 1.6 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.3 | 0.5 | GO:0045714 | regulation of low-density lipoprotein particle clearance(GO:0010988) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.3 | 1.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 1.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.3 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 1.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.3 | 1.0 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.3 | 0.8 | GO:0007567 | parturition(GO:0007567) |
0.3 | 0.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.3 | 0.5 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 0.8 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 3.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 1.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 1.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 1.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 2.8 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 1.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.3 | 1.0 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.3 | 2.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.3 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.3 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 4.5 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 0.7 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.2 | 1.7 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.5 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 3.7 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.2 | 2.9 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 3.4 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 2.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.2 | 0.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.2 | 2.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 0.7 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.2 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.2 | 0.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.2 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.2 | 9.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 0.7 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.2 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 8.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.2 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 1.2 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 2.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 1.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 2.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 1.8 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.2 | 1.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.9 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.2 | 2.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 1.6 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.2 | 2.3 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.2 | 1.6 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 2.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 2.7 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 1.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 1.6 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.7 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 1.3 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.2 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.2 | 2.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 1.5 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 7.7 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.2 | 1.5 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 2.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.7 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.2 | 0.7 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.2 | 1.5 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.2 | 1.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 2.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.4 | GO:0015669 | gas transport(GO:0015669) |
0.2 | 1.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.2 | GO:0072275 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 1.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 1.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.4 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.2 | 1.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.4 | GO:0006415 | translational termination(GO:0006415) |
0.2 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.2 | 2.5 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.2 | 0.2 | GO:0046083 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.2 | 1.0 | GO:0033273 | response to vitamin(GO:0033273) |
0.2 | 0.4 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 1.9 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 2.3 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.2 | 1.5 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 0.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 1.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 0.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 0.6 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.2 | 0.2 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 2.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.2 | 0.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 0.8 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.2 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 0.4 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.2 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.2 | 1.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.2 | 0.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 5.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.2 | 0.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 1.2 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.2 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 3.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 3.6 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 1.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.2 | 2.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 4.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 2.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.2 | 1.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 1.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.8 | GO:0043987 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.2 | 1.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 0.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 5.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.6 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.2 | 0.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 3.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 1.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.2 | 1.2 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.6 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.2 | 3.5 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 1.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.2 | 0.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 1.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.2 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.4 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.2 | 0.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 4.3 | GO:0006414 | translational elongation(GO:0006414) |
0.2 | 1.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.9 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 0.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.2 | 1.5 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.2 | 1.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.2 | 1.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 4.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 3.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.2 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 0.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 5.8 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.2 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.2 | 0.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 2.2 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.2 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.2 | 0.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.2 | 0.5 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.2 | 0.5 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 5.2 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.2 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.3 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 0.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.2 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 0.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 2.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 0.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.7 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.2 | 0.9 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.7 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.9 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 2.6 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.2 | 3.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 5.0 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.2 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.2 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 0.2 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.2 | 0.5 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.2 | 0.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.2 | 0.9 | GO:0006907 | pinocytosis(GO:0006907) |
0.2 | 0.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.0 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
0.2 | 0.7 | GO:0002931 | response to ischemia(GO:0002931) |
0.2 | 0.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 1.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.2 | 1.0 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.2 | 0.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.2 | 1.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.2 | 0.5 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 0.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 1.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.3 | GO:0071616 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.2 | 0.7 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 5.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 6.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 1.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.5 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 0.8 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.2 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 0.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 1.0 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 1.8 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 2.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.2 | 0.3 | GO:0019614 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.2 | 0.6 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.2 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.6 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 0.2 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.8 | GO:2000757 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.5 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 0.3 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 1.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 0.5 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 2.2 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.6 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.2 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.2 | 1.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 1.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.2 | 0.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 2.9 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.2 | 0.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 1.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.7 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.1 | 0.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.1 | GO:0070423 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.6 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.1 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 1.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.6 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.1 | 0.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 2.9 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.1 | 0.4 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.6 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.8 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.6 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 1.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 1.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 0.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 0.4 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 0.3 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 1.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.6 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.1 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 1.1 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.7 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 1.4 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.3 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.1 | 1.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.3 | GO:0070741 | response to interleukin-6(GO:0070741) |
0.1 | 4.3 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 2.4 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.5 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.1 | 1.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.1 | 1.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.1 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.1 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.3 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 0.3 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 1.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 2.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 2.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.3 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.0 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.1 | GO:0097212 | oxygen metabolic process(GO:0072592) lysosomal membrane organization(GO:0097212) |
0.1 | 0.4 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.1 | 1.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.1 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.9 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 3.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.3 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 1.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.1 | 4.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.9 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.1 | 0.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.1 | 1.4 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 3.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.2 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.1 | 0.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 8.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.2 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 2.6 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.1 | 0.4 | GO:0051304 | chromosome separation(GO:0051304) |
0.1 | 0.1 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 1.2 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.1 | 0.1 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.1 | 0.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 1.0 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 6.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.3 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 1.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.2 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 1.0 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.1 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 1.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 4.4 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.1 | 1.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 1.1 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.3 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.4 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 1.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.5 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) |
0.1 | 0.4 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 1.5 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.3 | GO:1903309 | negative regulation of chromatin modification(GO:1903309) |
0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.1 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 3.2 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.1 | 0.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
0.1 | 0.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 1.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 0.7 | GO:0009145 | purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 0.6 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.4 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.1 | 2.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 1.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 3.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 1.0 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.1 | 0.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 18.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 2.1 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.2 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
0.1 | 0.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.1 | 0.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.1 | 0.1 | GO:0003163 | sinoatrial node development(GO:0003163) |
0.1 | 2.2 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.8 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 1.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.1 | GO:0000237 | leptotene(GO:0000237) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.2 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.7 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 1.0 | GO:1900003 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.2 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 1.7 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.1 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.3 | GO:0051196 | regulation of coenzyme metabolic process(GO:0051196) |
0.1 | 0.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 0.2 | GO:0050932 | regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
0.1 | 1.0 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.1 | 0.2 | GO:1903580 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
0.1 | 0.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.1 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.2 | GO:0070163 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.1 | 0.6 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.1 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.5 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 0.6 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.9 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.4 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.1 | 0.4 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 1.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.5 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.1 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.1 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 1.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.5 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.1 | 0.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0007584 | response to nutrient(GO:0007584) |
0.1 | 0.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.6 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.2 | GO:0043328 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.1 | 0.2 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.1 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
0.1 | 0.2 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.1 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) D-amino acid metabolic process(GO:0046416) |
0.1 | 0.2 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.1 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.2 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.5 | GO:0042269 | regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.1 | 0.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.1 | 0.4 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.1 | 0.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.1 | 0.1 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.1 | 2.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.1 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.3 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 0.1 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.0 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.0 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.4 | GO:0097369 | sodium ion import(GO:0097369) |
0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.0 | GO:0002886 | regulation of myeloid leukocyte mediated immunity(GO:0002886) |
0.0 | 0.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.0 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.3 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.0 | 0.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.0 | 0.1 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 1.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.2 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.0 | 0.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 2.3 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.0 | 0.0 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.0 | 0.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.0 | 0.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.1 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.0 | 0.1 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.2 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.0 | 0.4 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.0 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.0 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.0 | 0.2 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.0 | 0.3 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.0 | 0.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.0 | 0.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0006743 | ubiquinone metabolic process(GO:0006743) quinone biosynthetic process(GO:1901663) |
0.0 | 1.7 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 1.6 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 1.3 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.0 | 1.4 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0034340 | response to type I interferon(GO:0034340) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.0 | GO:0097028 | dendritic cell differentiation(GO:0097028) |
0.0 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.1 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) |
0.0 | 0.2 | GO:0060142 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) |
0.0 | 0.6 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.0 | 0.1 | GO:0003093 | regulation of glomerular filtration(GO:0003093) |
0.0 | 0.1 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.0 | 0.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.0 | 0.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.0 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.0 | 0.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.0 | 0.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.1 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0033572 | transferrin transport(GO:0033572) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) |
0.0 | 0.7 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.6 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.2 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.0 | 0.0 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.8 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.4 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.0 | 0.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.0 | 0.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.0 | GO:0061450 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.0 | 0.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.0 | 0.1 | GO:1901068 | guanosine-containing compound metabolic process(GO:1901068) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.0 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
0.0 | 0.0 | GO:1990266 | neutrophil migration(GO:1990266) |
0.0 | 0.0 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.0 | 0.9 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.0 | 0.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.9 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 1.9 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.9 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.0 | 0.6 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.0 | 0.4 | GO:0030168 | platelet activation(GO:0030168) |
0.0 | 0.0 | GO:0071621 | granulocyte chemotaxis(GO:0071621) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.0 | 0.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.1 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.0 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.2 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.0 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.0 | 0.0 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.0 | GO:0043489 | RNA stabilization(GO:0043489) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.0 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.0 | 0.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 11.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.7 | 8.5 | GO:0005579 | membrane attack complex(GO:0005579) |
1.1 | 4.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.1 | 7.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.1 | 3.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.9 | 3.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.9 | 9.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 8.9 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.9 | 4.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.9 | 2.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 13.8 | GO:0002102 | podosome(GO:0002102) |
0.8 | 2.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.8 | 2.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.8 | 2.3 | GO:0032437 | cuticular plate(GO:0032437) |
0.7 | 2.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.7 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 5.8 | GO:0042581 | specific granule(GO:0042581) |
0.7 | 2.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.7 | 2.6 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.7 | 1.3 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 3.9 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 2.5 | GO:0016460 | myosin II complex(GO:0016460) |
0.6 | 3.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.6 | 3.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.6 | 7.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.5 | 2.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.5 | 3.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.5 | 5.3 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 1.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.5 | 4.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.5 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.5 | 0.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 3.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 2.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.5 | 1.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.5 | 1.5 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.5 | 1.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.5 | 1.9 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.5 | 2.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 2.4 | GO:0000796 | condensin complex(GO:0000796) |
0.5 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.5 | 1.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.5 | 2.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.5 | 4.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.5 | 1.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 6.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.4 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.4 | 6.9 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.7 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 1.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.4 | 1.7 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 1.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 3.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.4 | 3.3 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 1.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.4 | 4.4 | GO:0042555 | MCM complex(GO:0042555) |
0.4 | 1.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.4 | 1.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 2.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 3.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.4 | 1.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 1.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.4 | 1.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 1.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 1.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.4 | 1.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.4 | 1.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 1.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 1.1 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.4 | 0.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.4 | 26.1 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.4 | 1.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.4 | 3.4 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.4 | 3.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 1.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 0.7 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 5.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.5 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 1.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.4 | 3.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.4 | 0.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.4 | 3.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.4 | 0.7 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 2.9 | GO:0000243 | commitment complex(GO:0000243) |
0.4 | 1.1 | GO:0097413 | Lewy body(GO:0097413) |
0.4 | 0.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 1.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 3.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.3 | 2.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 6.7 | GO:0036379 | myofilament(GO:0036379) |
0.3 | 7.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 2.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 1.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 21.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 1.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 1.7 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 13.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 8.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 3.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 2.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 3.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 2.0 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 7.1 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 4.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 0.6 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.3 | 7.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.6 | GO:0099738 | apical cortex(GO:0045179) cell cortex region(GO:0099738) |
0.3 | 7.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 3.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 1.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.3 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 24.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 4.5 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.3 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 2.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 1.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.3 | 9.0 | GO:0015030 | Cajal body(GO:0015030) |
0.3 | 1.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 0.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 4.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 2.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 13.3 | GO:0005657 | replication fork(GO:0005657) |
0.3 | 1.4 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 0.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 1.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.3 | 3.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 5.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 0.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 1.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.3 | 3.1 | GO:0005685 | U1 snRNP(GO:0005685) |
0.3 | 1.0 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.3 | 3.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 0.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.3 | 21.2 | GO:0000793 | condensed chromosome(GO:0000793) |
0.3 | 8.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 3.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 0.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 5.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 1.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 2.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.4 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 2.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 1.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 7.7 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 2.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 2.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 11.1 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 0.4 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 2.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.7 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 5.9 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 16.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 1.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 7.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 7.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 11.1 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 12.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 0.4 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 1.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 0.6 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 0.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 5.2 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.2 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.2 | 7.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 4.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 14.4 | GO:0005819 | spindle(GO:0005819) |
0.2 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 2.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 8.8 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.2 | 1.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 0.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 5.5 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 7.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 7.1 | GO:0016605 | PML body(GO:0016605) |
0.2 | 1.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 3.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 2.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.8 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 11.5 | GO:0005938 | cell cortex(GO:0005938) |
0.2 | 6.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 0.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.7 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.2 | 0.2 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.2 | 1.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.2 | 1.0 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 2.4 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 2.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.2 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 1.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.2 | 0.5 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 6.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 0.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.2 | 3.9 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) omegasome(GO:1990462) |
0.2 | 0.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 5.6 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.1 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 4.7 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 6.6 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.4 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 5.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 4.8 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 5.5 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.9 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 11.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 1.1 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 3.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 1.4 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 14.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.2 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 56.8 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 4.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 10.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.6 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.5 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.1 | 0.2 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 2.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.2 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 16.0 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 31.5 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 10.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 3.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 94.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.2 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.4 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.1 | 0.4 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.2 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.5 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.5 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 3.8 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 1.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 52.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.2 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 5.4 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 4.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.1 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 67.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 1.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 4.7 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.1 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 1.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 7.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.8 | 5.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.5 | 9.1 | GO:0004064 | arylesterase activity(GO:0004064) |
1.5 | 4.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.4 | 4.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.3 | 6.4 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.2 | 4.8 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
1.2 | 4.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 3.5 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.2 | 2.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.2 | 8.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.2 | 5.8 | GO:0016936 | galactoside binding(GO:0016936) |
1.1 | 4.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
1.1 | 1.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.1 | 4.3 | GO:0031433 | telethonin binding(GO:0031433) |
1.1 | 5.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.1 | 3.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
1.1 | 3.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.0 | 3.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.0 | 4.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 5.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.0 | 1.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
1.0 | 4.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.0 | 3.9 | GO:0009374 | biotin binding(GO:0009374) |
1.0 | 6.7 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.9 | 2.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.9 | 2.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.9 | 1.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.9 | 2.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.9 | 2.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.9 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.9 | 7.9 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.8 | 5.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.8 | 4.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 3.3 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.8 | 2.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 4.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.8 | 4.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.8 | 2.3 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 2.3 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.8 | 2.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 2.3 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.8 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 5.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.8 | 7.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.7 | 4.5 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.7 | 2.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.7 | 4.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.7 | 2.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 2.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.7 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 2.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.7 | 2.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 4.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 2.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 2.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.7 | 2.8 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.7 | 4.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.7 | 16.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.7 | 2.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.7 | 2.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.7 | 2.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 1.9 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 3.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 4.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.6 | 1.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 6.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 1.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 2.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.6 | 1.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.6 | 11.6 | GO:0001848 | complement binding(GO:0001848) |
0.6 | 1.8 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 6.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.6 | 12.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.6 | 2.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.6 | 2.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 1.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 11.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.6 | 6.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.6 | 1.7 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.6 | 1.7 | GO:1990188 | euchromatin binding(GO:1990188) |
0.6 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.6 | 4.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.6 | 2.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 2.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.6 | 27.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 0.5 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.5 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 2.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.5 | 2.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 0.5 | GO:0045340 | mercury ion binding(GO:0045340) |
0.5 | 3.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.6 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.5 | 1.5 | GO:0019862 | IgA binding(GO:0019862) |
0.5 | 0.5 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.5 | 1.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.5 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.5 | 8.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 2.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.5 | 1.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.5 | 1.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.5 | 2.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 2.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 1.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 3.8 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.5 | 3.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.5 | 1.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 1.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 2.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.5 | 7.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.5 | 2.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.5 | 6.0 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 2.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 2.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.5 | 1.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 2.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 2.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.5 | 3.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.4 | 2.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 1.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.4 | 2.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.4 | 0.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.4 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 2.6 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 9.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 0.4 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.4 | 3.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.4 | 9.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.4 | 1.7 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.4 | 3.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.4 | 2.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 2.9 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.4 | 0.4 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 1.2 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 2.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.4 | 2.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.4 | 0.8 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.4 | 0.8 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 2.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 2.4 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 0.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 8.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 1.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.4 | 4.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.4 | 1.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 3.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 11.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 3.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 1.2 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.4 | 1.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.4 | 0.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 1.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.4 | 3.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 1.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.4 | 0.8 | GO:0016151 | nickel cation binding(GO:0016151) |
0.4 | 1.5 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 0.8 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.4 | 1.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.4 | 3.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.4 | 2.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.4 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 18.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.4 | 1.1 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.4 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 2.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.4 | 8.3 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 1.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 1.8 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.4 | 0.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 2.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 2.5 | GO:0051735 | cobinamide kinase activity(GO:0008819) phytol kinase activity(GO:0010276) phenol kinase activity(GO:0018720) cyclin-dependent protein kinase activating kinase regulator activity(GO:0019914) inositol tetrakisphosphate 2-kinase activity(GO:0032942) heptose 7-phosphate kinase activity(GO:0033785) aminoglycoside phosphotransferase activity(GO:0034071) eukaryotic elongation factor-2 kinase regulator activity(GO:0042556) eukaryotic elongation factor-2 kinase activator activity(GO:0042557) LPPG:FO 2-phospho-L-lactate transferase activity(GO:0043743) cytidine kinase activity(GO:0043771) glycerate 2-kinase activity(GO:0043798) (S)-lactate 2-kinase activity(GO:0043841) phosphoserine:homoserine phosphotransferase activity(GO:0043899) L-seryl-tRNA(Sec) kinase activity(GO:0043915) phosphocholine transferase activity(GO:0044605) GTP-dependent polynucleotide kinase activity(GO:0051735) farnesol kinase activity(GO:0052668) CTP:2-trans,-6-trans-farnesol kinase activity(GO:0052669) geraniol kinase activity(GO:0052670) geranylgeraniol kinase activity(GO:0052671) CTP:geranylgeraniol kinase activity(GO:0052672) prenol kinase activity(GO:0052673) 1-phosphatidylinositol-5-kinase activity(GO:0052810) 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.4 | 1.8 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 0.7 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.0 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.0 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 3.8 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 1.0 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 3.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.3 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.3 | 2.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 6.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 3.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 1.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 2.6 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 2.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 1.0 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 0.3 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.3 | 5.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.3 | 1.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.3 | 2.5 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.3 | 1.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.3 | 0.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 1.9 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 0.3 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 3.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 1.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.3 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 3.1 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.3 | 2.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.3 | 1.2 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.3 | 2.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 0.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.3 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 0.9 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 3.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 1.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.3 | 2.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 2.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.3 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 16.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.3 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 3.2 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 2.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 2.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 1.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 3.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 0.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 2.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.3 | 1.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 2.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 3.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 4.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 3.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.3 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.3 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 1.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 0.6 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 4.4 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.3 | 2.5 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 9.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 5.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.3 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 0.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 4.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.3 | 1.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 1.1 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.3 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 3.5 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.3 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.3 | 1.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 4.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 1.8 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.3 | 3.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 0.8 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 0.8 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 1.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.3 | 1.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.5 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 4.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 3.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 0.3 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 4.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 1.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 3.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 4.4 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.7 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.2 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 0.7 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 4.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 0.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.2 | 0.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 1.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 0.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.2 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 4.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.2 | 0.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 2.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.1 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.2 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.2 | 1.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 4.5 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 1.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.7 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.2 | 2.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.2 | 0.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.1 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 2.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 0.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 0.6 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 1.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.6 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 4.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.2 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.6 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.2 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.2 | 0.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 7.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 2.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 8.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 1.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 2.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.2 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
0.2 | 0.4 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 0.6 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 1.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 2.6 | GO:0004601 | peroxidase activity(GO:0004601) |
0.2 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 1.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 2.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 3.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 2.9 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 1.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 34.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 10.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 12.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.2 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 5.4 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.2 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 4.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 2.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.2 | 0.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 1.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 5.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 4.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 7.0 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 0.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.2 | 0.2 | GO:0003896 | DNA primase activity(GO:0003896) |
0.2 | 0.9 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 0.5 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.2 | 1.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 4.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 1.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 4.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 3.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 7.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 1.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.2 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.8 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 1.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.2 | 0.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 4.2 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 1.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.3 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.8 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 9.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.2 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.5 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.2 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.6 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 6.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 2.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 0.5 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 1.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.2 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 4.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 2.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 2.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 6.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.4 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 1.7 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 3.0 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.1 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 1.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 2.0 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.8 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 2.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.5 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 1.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 12.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 1.7 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.1 | 0.4 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.1 | 3.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 4.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 1.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 5.7 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 3.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 5.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 3.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 8.6 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 1.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.7 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 1.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.5 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.3 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 1.7 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.1 | GO:0060230 | lipase activator activity(GO:0060229) lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.6 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 4.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 4.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.8 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 1.3 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.1 | 11.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.1 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.1 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 7.6 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 2.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 1.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.9 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 1.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.1 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.7 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 2.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 2.6 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 2.6 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.4 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 2.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 2.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.1 | 1.1 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 0.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.8 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 4.0 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 0.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 0.2 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 1.1 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
0.1 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 2.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.7 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.1 | GO:0034560 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) tocotrienol omega-hydroxylase activity(GO:0052872) thalianol hydroxylase activity(GO:0080014) |
0.1 | 2.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 5.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 10.9 | GO:0043773 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.1 | 1.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 9.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0090484 | drug transporter activity(GO:0090484) |
0.1 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.9 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.1 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 1.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 35.6 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 0.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.8 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.9 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 1.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 0.5 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 8.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.0 | 0.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.0 | 1.1 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.0 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.0 | 7.4 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 3.4 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.0 | 0.0 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.7 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 3.2 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.0 | 0.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.4 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.1 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.7 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.0 | 1.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 1.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 14.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 10.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.7 | 5.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 0.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.6 | 2.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 3.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.6 | 0.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 24.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 8.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 13.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.5 | 6.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 2.7 | ST STAT3 PATHWAY | STAT3 Pathway |
0.5 | 8.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.5 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 18.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 14.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.5 | 6.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 12.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 10.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.4 | 5.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 6.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 1.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.3 | 13.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 3.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 9.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 12.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.3 | 6.1 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 5.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 14.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 2.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 5.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 2.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 3.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 6.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 10.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 3.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 6.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 1.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 1.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 1.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.3 | 3.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 5.6 | PID E2F PATHWAY | E2F transcription factor network |
0.3 | 13.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 2.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 12.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 4.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 3.2 | PID ATM PATHWAY | ATM pathway |
0.2 | 3.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 4.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 8.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 7.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 0.2 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 1.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 11.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 4.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 4.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 2.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 1.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 3.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 3.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 1.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 2.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 1.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 3.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 1.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 0.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 6.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 0.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 0.8 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 2.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.9 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 21.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.2 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 1.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 2.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 1.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 21.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.3 | 13.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 9.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 4.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 13.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.8 | 0.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.7 | 6.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.7 | 5.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.7 | 6.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 9.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 1.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 8.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.6 | 12.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.6 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 9.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.6 | 6.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.6 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 6.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.5 | 8.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.5 | 12.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 8.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.5 | 12.7 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.5 | 8.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 9.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.5 | 0.5 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.5 | 3.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 13.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 7.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 2.9 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.5 | 1.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.5 | 3.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 3.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.5 | 3.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.5 | 1.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 4.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.5 | 3.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 4.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 1.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.4 | 4.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.4 | 2.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 3.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.4 | 5.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 1.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 32.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 4.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 12.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 8.8 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.4 | 5.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 3.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 5.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 11.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 1.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.4 | 3.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 3.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 5.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 5.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 2.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 3.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 31.5 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 4.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.3 | 5.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 2.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 0.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.3 | 10.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.3 | 8.1 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.3 | 0.3 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.3 | 3.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.3 | 9.3 | REACTOME TRANSLATION | Genes involved in Translation |
0.3 | 3.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 6.0 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.3 | 1.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 8.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 6.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 6.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.1 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 13.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 9.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 5.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.3 | 2.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 4.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 6.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 2.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 2.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 13.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 26.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 3.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 24.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 2.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 1.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 13.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.3 | 1.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 7.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.3 | 1.6 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 6.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 3.2 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.3 | 1.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 6.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 2.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 3.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 2.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 5.0 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 2.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 2.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 2.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 2.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 15.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 2.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 4.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 3.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 6.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 2.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 2.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 8.9 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 1.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.2 | 4.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 1.0 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 2.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 3.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 1.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 1.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 2.0 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.2 | 3.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.3 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.2 | 1.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 0.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 4.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 1.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 3.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 12.3 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.2 | 1.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 3.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 1.9 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 1.1 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.8 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.1 | 2.5 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 2.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 1.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.7 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 12.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 2.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 7.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 4.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 2.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.3 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.3 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.8 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 0.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 3.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 0.4 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 3.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.0 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.2 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.4 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 0.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.3 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 0.5 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.0 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |